Skip to main content
X

Original Contribution

Original Contribution

This is a pilot feasibility study and the objective is to evaluate the safety and effectiveness of the investigational device, IN.PACT 014 drug-coated balloon, compared with standard PTA in patients with CLI with CTOs of BTK arteries. 

Original Contribution

Previous studies have suggested that Black patients with peripheral artery disease (PAD) may have worse outcomes than White patients. The aim of this study was to determine whether there are racial differences in outcomes of patients with PAD undergoing endovascular treatment.

Original Contribution

This analysis seeks to describe the technique of ultrasound-assisted percutaneous superficial femoral arterial access closure with a Mynx device (Cordis Corporation). The study aim was to demonstrate the technical considerations, benefits, efficacy, and safety of this technique.

Original Contribution

Below-the-knee peripheral arterial disease more often presents as critical limb ischemia. Endovascular revascularization strategies continue to evolve to achieve long-term limb-salvage outcomes. A single-center experience with optical coherence tomography-guided atherectomy using Pantheris SV (Avinger) is reported.

Original Contribution

The Outback device (Cordis) enables true lumen re-entry during subintimal recanalization of CTOs. This study compared outcomes of patients who underwent subintimal recanalization of lower-extremity arterial CTOs utilizing the Outback device via antegrade and retrograde approaches.

Original Contribution

The aim of the study was to evaluate the safety and short-term efficacy of the Ranger paclitaxel-coated balloon (PCB; Boston Scientific) in the setting of CLI. 

Original Contribution

To understand the impact of fluence and repetition rate on outcomes of superficial femoral artery and popliteal artery laser atherectomy based on lesion type (calcific, homogenous, heterogeneous, and restenosis).